Hoạt tính kháng sinh của hợp chất tự nhiên từ chủng Aspergillus Flocculosus 01NT.1.1.5 phân lập từ bọt biển

Các loài vi nấm Aspergillus được xem là nguồn quan trọng cho các hợp chất tự nhiên ứng dụng trong y dược, nông nghiệp và công nghiệp. Trong tiến trình nghiên cứu của chúng tôi về các hợp chất kháng sinh mới từ vi nấm biển, một hợp chất mới phomaligol A2 (1), cùng với ba hợp chất đã biết wasabidienone E (2), aspertetranone D (3) và mactanamide (4) được thu nhận từ dịch chiết etyl acetate môi trường lên men chủng vi nấm biển Aspergillus flocculosus (A. flocculosus) 01NT.1.1.5 phân lập từ loài bọt biển Stylissa sp. thu ở vịnh Nha Trang, Việt Nam. Cấu trúc hoá học của các hợp chất này được xác định bởi phân tích dữ liệu phổ công hưởng từ hạt nhân 1 chiều, 2 chiều và phổ khối, đồng thời so sánh với các dữ liệu tương ứng với các công trình nghiên cứu trước đây. Bên cạnh đó, nghiên cứu cũng tiến hành đánh giá hoạt tính kháng sinh của các hợp chất thu được đối với các chủng vi sinh gây bệnh bao gồm Escherichia coli (E. coli) ATCC 25922, Pseudomonas aeruginosa (P. aeruginosa) ATCC 27853, Staphylococcus aureus (S. aureus) ATCC 25923, Bacillus cereus (B. cereus) ATCC 11778, Streptococcus faecalis (S. faecalis) ATCC 19433, Listeria monocytogenes (L. monocytogenes) ATCC 19111, and Candida albicans (C. albicans) ATCC 10231. Trong số các hợp chất này, hợp chất 1-3 ức chế sự tăng trưởng của nấm men C. albicans với nồng độ ức chế tối thiểu (MIC) là 16 µg/mL. Hoạt tính của các hợp chất này hiệu quả hơn khi so sánh với amoxicillin và cefotaxime (MIC > 256 µg/mL), thuốc kháng sinh được sử dụng làm đối chứng dương. Bên cạnh đó, các hợp chất 1-4 cũng thể hiện hoạt tính kháng các chủng vi khuẩn gây bệnh khác bao gồm P. aeruginosa và S. faecalis với MIC lần lượt 16 µg/mL và 32 µg/mL. Hợp chất 4 không có hoạt tính ức chế đối với chủng L. monocytogenes, trong khi các hợp chất 1-3 có khả năng kháng chủng này với MIC từ 32 đến 64 µg/mL. Bốn hợp chất thử nghiệm đều thể hiện hoạt tính kháng khuẩn đối với chủng B. cereus và E. coli với các giá trị MIC 64-128 µg/mL. Đây là báo cáo đầu tiên về các hợp chất có hoạt tính kháng sinh thu được từ chủng vi nấm biển A. flocculosus phân lập tại Việt Nam.

pdf7 trang | Chia sẻ: hachi492 | Lượt xem: 3 | Lượt tải: 0download
Bạn đang xem nội dung tài liệu Hoạt tính kháng sinh của hợp chất tự nhiên từ chủng Aspergillus Flocculosus 01NT.1.1.5 phân lập từ bọt biển, để tải tài liệu về máy bạn click vào nút DOWNLOAD ở trên
Journal of Biotechnology 16(4): 729-735, 2018 729 ANTIMICROBIAL ACTIVITY OF NATURAL COMPOUNDS FROM SPONGE – DERIVED FUNGUS ASPERGILLUS FLOCCULOSUS 01NT.1.1.5 Phan Thi Hoai Trinh1,4,*, Tran Thi Thanh Van1,4, Bui Minh Ly1,4, Byeoung Kyu Choi2, Hee Jae Shin2, Jong Seok Lee2, Hyi Seung Lee2, Phi Quyet Tien3,4 1Nhatrang Institute of Technology Research and Application, Vietnam Academy of Science and Technology 2Korea Institute of Ocean Science and Technology, Busan, Korea 3Institute of Biotechnology, Vietnam Academy of Science and Technology 4Graduate University of Science and Technology, Vietnam Academy of Science and Technology * To whom correspondence should be addressed. E-mail: phanhoaitrinh84@gmail.com Received: 28.6.2018 Accepted: 20.12.2018 SUMMARY The Aspergillus fungi have been an important source of natural products that are useful for exploration in medicine, agriculture and industry. In our continuous investigation to search for new antimicrobial agents from marine-derived fungi, one new phomaligol A2 (1), together with three known compounds, wasabidienone E (2), aspertetranone D (3) and mactanamide (4), were obtained from the EtOAc extract of the culture medium of the marine-derived fungus Aspergillus flocculosus (A. flocculosus) 01NT.1.1.5 isolated from the sponge Stylissa sp. at Nhatrang Bay, Vietnam. Their chemical structures were elucidated by analysis of 1D and 2D NMR and mass spectroscopic data, as well as by comparison of the corresponding data to those previously reported in the literature. Furthermore, the aim of this study was also to evaluate the antimicrobial activity of these compounds against pathogenic microbes including Escherichia coli (E. coli) ATCC 25922, Pseudomonas aeruginosa (P. aeruginosa) ATCC 27853, Staphylococcus aureus (S. aureus) ATCC 25923, Bacillus cereus (B. cereus) ATCC 11778, Streptococcus faecalis (S. faecalis) ATCC 19433, Listeria monocytogenes (L. monocytogenes) ATCC 19111, and Candida albicans (C. albicans) ATCC 10231. Among the compounds, 1-3 were inhibitory on the growth of the yeast C. albicans with minimum inhibitory concentration (MIC) value of 16 µg/mL, which was more potent than amoxicillin and cefotaxime (MIC > 256 µg/mL), antimicrobial drugs as positive references. Moreover, compounds 1-4 were also found to be active against other pathogens including P. aeruginosa and S. faecalis with MIC values of 16 µg/mL and 32 µg/mL, respectively. Compound 4 had no inhibitory activity against L. monocytogenes, whereas compounds 1-3 had ability to against this strain with MICs of 32 to 64 µg/mL. Four of tested compounds exhibited antibacterial activity against B. cereus and E. coli with MIC values of 64-128 µg/mL. This is the first report about these compounds with antimicrobial activity obtained from marine fungus A. flocculosus isolated in Vietnam. Keywords: Aspergillus flocculosus, antimicrobial activity, aspertetranone D, mactanamide, phomaligol A2, wasabidienone E. INTRODUCTION Nowadays, in spite of the advance in human drugs, infectious diseases related to the emergence of pathogens, are still major issues in public healthy worldwide, especially in developing countries. The widespread of antimicrobial resistance microbes has been reported over the world that demands more effective antimicrobial compounds. Despite the impressive advance in producing antimicrobial substances by chemical and bio-engineered synthesis, nature particularly marine environment has still considered as the richest source for new antimicrobial compounds (Blunt et al., 2010). Novel antimicrobial compounds from marine microbes have been increasingly discovered in recent years (Du et al., 2014; Habbu et al., 2016; Handayani et al., 2015). So far, a great number of antimicrobial compounds have been found in a handful of the one million different microbial species (Brown et al., 2014). Natural metabolites from marine fungi are considered an important source for novel Phan Thi Hoai Trinh et al. 730 antimicrobial compounds because of their abundant fungal species diversity, their rich secondary metabolites and the improvements in their genetic breeding and fermentation processes (Li et al., 2014; Du et al., 2014). The Aspergillus genus has more than one hundred species, and belongs to the Ascomycota division, Deuteromycotina subdivision, Hyphomycetes class, Moniliales order, Moniliaceae family. The species are widely found in nature and diverse in marine ecosystems, are well known for producing antimicrobial and anticancer compounds, bio- surfactants, etc. (Li, 2010). Thus, the Aspergillus fungi have been an important source of natural products useful for exploration in medicine, agriculture and industry (Petersen et al., 2015). As part of a continuing study to evaluate the drug potential of marine-derived fungi from Vietnam, we isolated and screened 100 fungal strains from various marine habitats at Nhatrang Bay for antimicrobial activity. Among them, the strain Aspergillus flocculosus (A. flocculosus) 01NT.1.1.5 was isolated from the sponge Stylissa sp. exhibited high activity against tested pathogens (Trinh et al., 2018). Therefore, the strain was analyzed further for causative secondary metabolites. As a result, one new phomaligol A2 (1), together with three known compounds, wasabidienone E (2) (Soga et al., 1987), aspertetranone (3) (Wang et al., 2015) and mactanamide (4) (Lorenz et al., 1998) were isolated and identified from this fungus. Furthermore, the isolated compounds were examined for antimicrobial activity. Details of the isolation, structure elucidation, and antibiotic activity of compounds 1– 4 are presented here. MATERIALS AND METHODS General experimental procedures 1D and 2D spectroscopic data were recorded on a Varian Unity 500 NMR spectrometer (MCKinley, Sparta, NJ). ESI-MS data were obtained on a Shimadzu hybrid ion-trap time-of-flight mass spectrometer (Shimadzu, Kyoto, Japan). HPLC was conducted on a column 250 mm x 10 mm i.d., S-5 µm, 12 nm, YMC-Pack-ODS-A, with a PrimeLine Binary pump with RI-101 Shodex, RI detector (Shoko Scientific Co., Yokohama, Japan). Fungal material The fungus A. flocculosus 01NT.1.1.5 was originally isolated from the sponge Stylissa sp. at Nhatrang Bay, Vietnam, in February 2016. The fungus was identified according to its gene sequence of 28S rDNA (GenBank accession number MG972941.1). A BLAST search results indicated that the sequence was similar 100% to the sequence of A. flocculosus NRRL 5224. The strain was named as A. flocculosus 01NT.1.1.5 and currently preserved in the Marine Microorganism Collection, Nhatrang Institute of Technology Research and Application (NITRA). Figure 1. Sponge Stylissa sp. (A) and fungus A. flocculosus 01NT.1.1.5 (B). A B Journal of Biotechnology 16(4): 729-735, 2018 731 Fermentation, extraction and isolation The fungal strain was grown stationary at 28oC for 20 days in 45 Erlenmeyer flasks (500 mL), each flask containing 20 g of rice, 20 mg of yeast extract, 10 mg of KH2PO4, and 40 mL of natural seawater (Sobolevskaya et al., 2016). At the end of the incubation period, mycelia and media were homogenized and extracted with EtOAc. The extract of the fungus was concentrated to dry using rotary evaporators at 40oC. The residual suspension (10 g) obtained from the culture of the fungal strain was subjected to ODS open column (200 mm x 50 mm i.d., C18) chromatography followed by stepwise gradient elution with MeOH in H2O (v/v) (20%, 40%, 60%, 80%, 100%, 2 L each) as the eluent. The fraction eluted with MeOH in H2O 40%-1 was utilized to purify compounds by analytical ODS HPLC (column YMC-Pack-ODS-A, 250 mm x 10 mm i.d., 5 µm, flow rate 3 mL/min; RI detector) using isocratic program with 15% ACN in H2O to yield compounds 1 (9.7 mg) and 2 (45.9 mg). The fraction eluted with MeOH in H2O 40%-3 was further purified by a preparative HPLC (column YMC-Pack-ODS-A, 250 mm x 10 mm i.d., 5 µm, flow rate 3 mL/min; RI detector) using isocratic program with 22% ACN in H2O to yield compounds 3 (30.8 mg) and 4 (4.9 mg). New phomaligol A2 (1): Yellow brown oil. ESI-MS m/z 300.88 [M + H]+, calcd. for C14H20O7. The 1H and 13C-NMR (CD3OD) was presented in Table 1. Wasabidienone E (2): Yellow oil. ESI-MS m/z 312.02 [M + H]+, calcd. for C16H25O5N. 1H-NMR (500 MHz, CD3OD) δH, J (Hz): 5.29 (1H, s, H-4), 2.50 (1H, m, H-8), 1.45, 1.72 (2H, m, H-9), 3.26 (2H, t, J = 8.5 Hz, H-10), 3.67 (2H, H- 11), 1.52 (3H, s, 2-Me), 3.94 (3H, s, 3-MeO), 1.69 (3H, s, 6-Me), 1.18 (3H, d, J = 10 Hz, 8-Me), 0.93 (3H, t, J = 15 Hz, 9-Me); 13C-NMR (125 MHz, CD3OD) δC: 192.4 (C-1), 99.9 (C-2), 174.8 (C-3), 78.6 (C-4), 164.0 (C-5), 78.1 (C-6), 175.1 (C-7), 40.1 (C-8), 26.0 (C-9), 44.4 (C-10), 58.8 (C-11), 26.8 (2-Me), 55.2 (3-MeO), 5.9 (6-Me), 15.5 (8-Me), 10.5 (9-Me). These spectroscopic data were suitable with the ones in the literature (Soga et al., 1987). Aspertetranone D (3): Cream solid. ESI-MS m/z 435.11 [M - H]-, calcd. for C22H28O9. 1H-NMR (500 MHz, CD3OD) δH, J (Hz): 4.34 (1H, s, H-6), 2.72, 2.80 (2H, d, J = 17, 18 Hz, H-10), 2.04 (1H, m, H-11), 2.34 (1H, dd, J = 9, 9.5 Hz, H- 11a), 4.58 (1H, d, J = 9 Hz, H-12), 2.25 (3H, s, 3- Me), 1.94 (3H, s, 4-Me), 1.40 (3H, s, 5a-Me), 1.33 (3H, s, 8-Meα), 1.37 (3H, s, 8-Meβ), 1.25 (3H, d, J = 7, 11-Me); 13C-NMR (125 MHz, CD3OD) δC: 164.5 (C-1), 157.7 (C-3), 107.7 (C-4), 163.6 (C-4a), 84.1 (C-5a), 73.3 (C-6), 75.5 (C-6a), 208.3 (C-7), 54.9 (C-8), 211.1 (C-9), 45.2 (C-10), 75.4 (C-10a), 39.2 (C-11), 39.8 (C-11a), 63.2 (C-12), 101.9 (C-12a), 15.8 (3-Me), 8.0 (4-Me), 16.8 (5a-Me), 24.4 (8- Meα), 22.6 (8-Meβ), 9.9 (11-Me). These spectroscopic data were suitable with the ones in the literature (Wang et al., 2015). Mactanamide (4): White powder. ESI-MS m/z 339.05 [M - H]-, calcd. for C19H20O4N2. 1H-NMR (500 MHz, CD3OD) δH, J (Hz): 2.84 (1H, dd, J = 11.5, 3.5 Hz, H-3), 4.21 (1H, m, H-6), 2.77, 3.11 (2H, dd, J = 7,5; 13,5/3,5; 13,5 Hz, H-7), 6.30 (1H, d, J = 7,5 Hz, H-10), 6.88 (1H, t, H-11), 6.30 (1H, d, H-12), 3.15, 3.18 (2H, dd, H-14), 7.26 (1H, br m, H-16), 7.12 (1H, br m, H-17), 7.25 (1H, br m, H-18), 7.12 (1H, br m, H-19), 7.26 (1H, br m, H-20), 3.02 (3H, s, H-21); 13C-NMR (125 MHz, CD3OD) δC: 168.6 (C-1), 53.7 (C-3), 168.6 (C-4), 63.9 (C-6), 24.4 (C-7), 109.5 (C-8), 156.3 (C-9), 106.7 (C-10), 127.9 (C-11), 106.7 (C-12), 156.3 (C- 13), 35.8 (C-14), 134.8 (C-15), 128.3 (C-16), 129.5 (C-17), 127.4 (C-18), 129.5 (C-19), 128.3 (C-20), 32.1 (C-21). These spectroscopic data were suitable for the ones in the literature (Lorenz et al., 1998). Antibacterial assay The minimum inhibitory concentrations (MICs) of active compounds against seven pathogens were determined by a dilution method (CLSI, 2016). First, 100 µL of Mueller Hinton Broth medium (MHB) was dispensed into all wells of a microtitre plate. Two-fold dilutions of the compounds in the range of 256-0.125 µg/mL were prepared in the plates. Amoxicillin and cefotaxime were used as positive controls. The turbidity of the microbial suspensions was measured at 600 nm wavelength, and adjusted to match the 0.5 McFarland standard (108 colony forming units/mL). Subsequently, 5 µL of bacterial culture was dispensed into each well 96-well plates. Finally, the plates were incubated at 37oC for 18-36 hours, and the MIC values were inspected as the lowest concentrations in which no growth could be observed. Antimicrobial assay was performed at least triplicate. Phan Thi Hoai Trinh et al. 732 RESULTS AND DISCUSSION The fungus was cultured for 20 days on rice medium. The EtOAc extract of the culture was purified by a combination of C18 gel column chromatography and reversed-phase HPLC to yield four individual compounds including one new phomaligol A2 (1), together with three known compounds, wasabidienone E (2), aspertetranone D (3) and mactanamide (4). Compound 1 was obtained as a yellow brown oil. The ESI-MS spectrum showed a quasimolecular ion peak at m/z 300.88 [M+H]+, corresponding to the molecular formula of C14H20O7. The 1H NMR spectrum of 1 (Table 1) exhibited signals for two methyl groups of cyclohexen ring (δH 1.55/H-13; 1.66/H-14), a methoxyl group (δH 3.89/H-12), and an aromatic proton (δH 5.62/H-4). Two olefinic carbons (δC 173.7/C-3 and 99.2/C-4), three ketone carbons (δC 202.2/C-1, 192.6/C-5 and 175.6/C-7), two oxygenated carbons (δC 72.7/C-2 and 82.2/C-6), and a methoxy carbon (δC 56.3/C-12) were observed in the 13C NMR data of 1 (Table 1). The 1H NMR spectrum of 1 also showed additional signals of two methyl groups (δH 1.22/H-10 and 1.23/ H-11), two methine protons (δH 2.46/H-8 and 3.84/H-9). The remaining six carbon signals were attributed to a sec-butyl (δC 20.2/C-10, 12.1/C-11, 68.4/C-9, and 46.5/C-8) and two methyl groups (δC 22.7/C-14, 20.7/C-13). The COSY spectrum showed coupling between terminal methyl protons (δH 1.22/ H-10) and methine proton (δH 3.84/H-9) which were coupled with a methine proton at δH 2.46 (H-8), which in turn coupled with a secondary methyl group (δH 1.23/H- 11) (Figure 3). 1 Wasabidienone E (2) Aspertetranone D (3) Mactanamide (4) Figure 2. Structures of compounds 1 - 4. Journal of Biotechnology 16(4): 729-735, 2018 733 In the HMBC spectrum, correlations were observed from the methyl protons H-10 (δH 1.22) and H-11 (δH 1.23) to carbons C-8 (δC 46.5) and at C-9 (δC 68.4). Furthermore, HMBC correlations from H3-13 (δH 1.55) to C-1 (δC 201.1) and C-2 (δC 72.7), from H3-14 (δH 1.66) to C-1 (δC 201.1), C-5 (δC 192.6) and C-6 (δC 82.2), and from H3-12 (δH 3.89) to C-3 (δC 173.7). Methine protons at δH 2.46 (H-8) showed HMBC correlations to the carbonyl carbon at δC 68.4 (C-9) and δC 12.1 (C-11). Methine protons at δH 3.84 (H-9) had HMBC correlations with C-11 (δC 12.1). Besides, HMBC spectrum also indicated the correlations from an aromatic proton H-4 (δH 5.62) to carbons C-2 (δC 72.7), C-3 (δC 173.7), C-5 (δC 192.6) and C-6 (δC 82.2) (Figure 3). Table 1. NMR data of compound 1. Pos. 1 Phomaligol A (Elbandy et al., 2009) δH, J (Hz) δC δH, J (Hz) δC 1 201.1 202.5 2 72.7 73.5 3 173.7 173.0 4 5.62 (1H, s) 99.2 5.56 (1H, s) 99.9 5 192.6 191.7 6 82.2 81.1 7 175.6 175.8 8 2.46 (1H, m) 46.5 2.50 (1H, m) 39.8 9 3.84 (1H, m) 68.4 1.73 (1H, m) 26.6 10 1.22 (3H, d, 6 Hz) 20.2 0.96 (3H, t, 7.5 Hz) 11.3 11 1.23 (3H, d, 7 Hz) 12.1 1.17 (3H, d, 7 Hz) 16.1 12 3.89 (3H, s) 56.3 3.87 (3H, s) 56.8 13 1.55 (3H, s) 20.7 1.65 (3H, s) 24.1 14 1.66 (3H, s) 22.7 1.70 (3H, s) 23.4 2-OH 3.65 (1H, s) 2.80 (1H, br s) 9-OH 3.58 (1H, s) The 1H and 13C NMR spectrum of 1 were nearly similar to that of phomaligol A, isolated from the sponge-derived fungus Paecilomyces lilacinus, except for the additional hydroxyl group located at C-9 (δH 3.58/OH-9, δC 68.4/C-9) (Elbandy et al., 2009). Thus, the compound 1 was assigned as a new compound and named phomaligol A2. Compounds 1–4 showed antimicrobial activity on E. coli, P. aeruginosa, S. aureus, B. cereus, S. faecalis, L. monocytogenes, and C. albicans with various values of minimum inhibitory concentration (MIC) (Table 2). Among these compounds, 1-3 exhibited antibiotic activities towards C. albicans with MIC of 16 µg/mL, whereas compound 4 showed antifungal activity against C. albicans with the MIC of 32 µg/mL. Similar report on the compound mactanamide isolated from marine- derived fungus Aspergillus sp., also demonstrated antibiotic activity towards C. albicans (Lorenz et al., 1998). Figure 3. Key COSY and HMBC correlations of 1. Phan Thi Hoai Trinh et al. 734 Table 2. Minimum inhibitory concentration (MIC, μg/mL) of compounds 1–4 against seven pathogens. Compounds E. coli P. aeruginosa S. aureus L. monocytogenes B. cereus S. faecalis C. albicans 1 64 16 128 32 128 32 16 2 64 16 64 64 128 32 16 3 64 16 64 32 64 32 16 4 128 16 64 > 256 64 32 32 Amoxcillin 8 128 0.25 0.25 > 256 > 256 256 Cefotaxime 0.25 4 0.5 64 64 4 > 256 Note: Amoxcillin and cefotaxime were positive drugs. Compounds 1-4 also demonstrated prominent antibacterial activity against P. aeruginosa (MIC 16 µg/mL), which were higher than that of the positive control amoxicillin (with MIC value of 128 µg/mL). Compound 4 did not illustrate antibacterial activity against L. monocytogenes. In conclusion, sponge- derived fungus A. flocculosus 01NT.1.1.5 might produce antibacterial secondary metabolites towards different microbes. It is believed that searching for natural products synthesized by marine fungi could be a promising way to combat the emerging of pathogens. CONCLUSION From the ethyl acetate extract of culture medium of a fungus A. flocculosus 01NT.1.1.5 isolated from the sponge Stylissa sp. at Nhatrang Bay, we obtained one new phomaligol A2 (1), together with three known compounds, wasabidienone E (2), aspertetranone D (3) and mactanamide (4). All of these compounds showed antimicrobial activity towards microorganisms with various values of MICs. The results indicated that marine fungus A. flocculosus 01NT.1.1.5 could produce natural compounds against pathogens. The remaining fractions and other bioactivities study of these compounds are conducting in advance. Acknowledgment: This study was supported by the project grant from No.3 branch component of the Project 47 (VAST.ĐA47.12/16-19). REFERENCES Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR (2010) Marine natural products. Nat Prod Rep 27(2): 165-237. Brown DG, Lister T, May-Dracka TL (2014) New natural products as new leads for antibacterial drug discovery. Bioorg Med Chem Lett 24(2): 413-418. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 2016, M100-S26. Du FY, Zhang P, Li XM, Li CS, Cui CM, Wang BG (2014) Cyclohexadepsipeptides of the isaridin class from the marine-derived fungus Beauveria felina EN-135. J Nat Prod 77(5): 1164–1169. Elbandy M, Shinde PB, Hong J, Bae KS, Kim MA, Lee SM, Jung JH (2009) α-Pyrones and yellow pigments from the sponge-derived fungus Paecilomyces lilacinus. Bull Korean Chem Soc 30(1): 188-192. Habbu P, Warad V, Shastri R, Madagundi S, Kulkarni VH (2016) Antimicrobial metabolites from marine microorganisms. Chin J Nat Med 14(2): 101-116. Handayani D, Ahdinur RF, Rustini R (2015) Antimicrobial Activity of Endophytic Fungi from Marine Sponge Haliclona fascigera. J Appl Pharm Sci 5(10): 154-156. Li SM (2010) Prenylated indole derivatives from fungi: structure diversity, biological activities, biosynthesis and chemoenzymatic synthesis. Nat Prod Rep 27(1): 57–58. Li X, Li XM, Xu GM, Li CS, Wang BG (2014) Antioxidant metabolites from marine alga-derived fungus Aspergillus wentii EN-48. Phytochem Lett 7: 120–123. Lorenz P, Jensen PR, Fenical W (1998) Mactanamide, a new fungistatic diketopiperazine produced by a marine Aspergillus sp. Nat Prod Lett 12(1): 55-60. Petersen LM, Kildgaard S, Jaspars M, Larsen TO (2015) Aspiperidine oxide, a piperidine N-oxide from the filamentous fungus Aspergillus indologenus. Tetrahedr Lett 56(14): 1847–1850. Sobolevskaya MP, Leshchenko EV, Hoai TP, Denisenko VA, Dyshlovoy SA, Kirichuk NN, Khudyakova YV, Kim NY, Berdyshev DV, Pislyagin EA, Kuzmich AS, Gerasimenko AV, Popov RS, von Amsberg G, Antonov AS, Afiyatullov SS (2016) Pallidopenillines: Journal of Biotechnology 16(4): 729-735, 2018 735 Polyketides from the Alga-Derived Fungus Penicillium thomii Maire KMM 4675. J Nat Prod 79(12): 3031-3038. Soga O, Iwamoto H, Ota Y, Odoi M, Saito K, Takuwa A, Nakayama M (1987) Wasabidienone-E, a new cyclohexandienone derivative containing hydroxyethylamino group, from potato culture solution of Phoma wasabiae Yokogi. Chem Lett 16(5): 815-816. Trinh PTH, Tien PQ, Ngoc NTD, Ly BM, Van TTT (2018) Isolation and screening marine fungi with antimicrobial activity from samples collected in Nha Trang Bay, Vietnam. J Biotechnol 16(1): 181-187. Wang Y, Qi S, Zhan Y, Zhang N, Wu AA, Gui F, Guo K, Yang Y, Cao S, Hu Z, Zheng Z, Song S, Xu Q, Shen Y, and Deng X (2015) Aspertetranones A−D, putative meroterpenoids from the marine algal-associated fungus Aspergillus sp. ZL0-1b14. J Nat Prod 78(10): 2405−2410. HOẠT TÍNH KHÁNG SINH CỦA HỢP CHẤT TỰ NHIÊN TỪ CHỦNG ASPERGILLUS FLOCCULOSUS 01NT.1.1.5 PHÂN LẬP TỪ BỌT BIỂN Phan Thị Hoài Trinh1,4, Trần Thị Thanh Vân1,4, Bùi Minh Lý1,4, Byeoung Kyu Choi2, Hee Jae Shin2, Jong Seok Lee2, Hyi Seung Lee2, Phí Quyết Tiến3,4 1Viện Nghiên cứu và Ứng dụng Công nghệ Nha Trang, Viện Hàn lâm Khoa học và Công nghệ Việt Nam 2Viện Khoa học và Công nghệ Hải dương Hàn Quốc, Busan, Hàn Quốc 3Viện Công nghệ Sinh học, Viện Hàn lâm Khoa học và Công nghệ Việt Nam 4Học viện Khoa học và Công nghệ, Viện Hàn lâm Khoa học và Công nghệ Việt Nam TÓM TẮT Các loài vi nấm Aspergillus được xem là nguồn quan trọng cho các hợp chất tự nhiên ứng dụng trong y dược, nông nghiệp và công nghiệp. Trong tiến trình nghiên cứu của chúng tôi về các hợp chất kháng sinh mới từ vi nấm biển, một hợp chất mới phomaligol A2 (1), cùng với ba hợp chất đã biết wasabidienone E (2), aspertetranone D (3) và mactanamide (4) được thu nhận từ dịch chiết etyl acetate môi trường lên men chủng vi nấm biển Aspergillus flocculosus (A. flocculosus) 01NT.1.1.5 phân lập từ loài bọt biển Stylissa sp. thu ở vịnh Nha Trang, Việt Nam. Cấu trúc hoá học của các hợp chất này được xác định bởi phân tích dữ liệu phổ công hưởng từ hạt nhân 1 chiều, 2 chiều và phổ khối, đồng thời so sánh với các dữ liệu tương ứng với các công trình nghiên cứu trước đây. Bên cạnh đó, nghiên cứu cũng tiến hành đánh giá hoạt tính kháng sinh của các hợp chất thu được đối với các chủng vi sinh gây bệnh bao gồm Escherichia coli (E. coli) ATCC 25922, Pseudomonas aeruginosa (P. aeruginosa) ATCC 27853, Staphylococcus aureus (S. aureus) ATCC 25923, Bacillus cereus (B. cereus) ATCC 11778, Streptococcus faecalis (S. faecalis) ATCC 19433, Listeria monocytogenes (L. monocytogenes) ATCC 19111, and Candida albicans (C. albicans) ATCC 10231. Trong số các hợp chất này, hợp chất 1-3 ức chế sự tăng trưởng của nấm men C. albicans với nồng độ ức chế tối thiểu (MIC) là 16 µg/mL. Hoạt tính của các hợp chất này hiệu quả hơn khi so sánh với amoxicillin và cefotaxime (MIC > 256 µg/mL), thuốc kháng sinh được sử dụng làm đối chứng dương. Bên cạnh đó, các hợp chất 1-4 cũng thể hiện hoạt tính kháng các chủng vi khuẩn gây bệnh khác bao gồm P. aeruginosa và S. faecalis với MIC lần lượt 16 µg/mL và 32 µg/mL. Hợp chất 4 không có hoạt tính ức chế đối với chủng L. monocytogenes, trong khi các hợp chất 1-3 có khả năng kháng chủng này với MIC từ 32 đến 64 µg/mL. Bốn hợp chất thử nghiệm đều thể hiện hoạt tính kháng khuẩn đối với chủng B. cereus và E. coli với các giá trị MIC 64-128 µg/mL. Đây là báo cáo đầu tiên về các hợp chất có hoạt tính kháng sinh thu được từ chủng vi nấm biển A. flocculosus phân lập tại Việt Nam. Keywords: Aspergillus flocculosus, aspertetranone D, hoạt tính kháng sinh, mactanamide, phomaligol A2, wasabidienone E

Các file đính kèm theo tài liệu này:

  • pdfhoat_tinh_khang_sinh_cua_hop_chat_tu_nhien_tu_chung_aspergil.pdf
Tài liệu liên quan